I agree with you. I don’t think it’s MGC’s neglect- it’s Cavalabs
For all we know MGC issued a cease and assist to CV when they used advertised formulated by MGC then did not sell the products.
No CBD products have been for sale on Cavalabs site for a month. An email I received from CV said the MGC line will be out mid year. They will
Ultimately the CV deal is a drop in the pond compared to what MGC can do. The $40mil is nice, but, even without the CV deal this stock is so undervalued
It seems to me every time there’s good news, the CV deal is brought up. Stop beating a dead horse- if you don’t trust management sell me your shares.
Cannepil at $1mil per 100 patients is the $$$$ Market here- MGC only owns 50% of Derma ($20mil to them). I’d guess they can grab 2000 patients out of the 1,270,000 in Europe and Australia to make up that $20mil if the CV deal tanks (I think a purple pig would fly through my house before that happens)
GW Pharma is basically giving Cannepil free marketing as its world wide news pending FDA approval for their treatment for Epilepsy in children
- Forums
- ASX - By Stock
- RGT
- where are you cavalabs?
where are you cavalabs?, page-24
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
23.0¢ |
Change
0.065(39.4%) |
Mkt cap ! $11.13M |
Open | High | Low | Value | Volume |
18.0¢ | 23.0¢ | 17.5¢ | $97.37K | 451.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 6921 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.180 |
3 | 24185 | 0.170 |
2 | 18040 | 0.165 |
2 | 21250 | 0.160 |
3 | 51527 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 6921 | 5 |
0.250 | 42478 | 4 |
0.260 | 100 | 1 |
0.300 | 338 | 1 |
0.345 | 5950 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |